Fujifilm to Start PII Avigan Trial for COVID-19 in US

April 10, 2020
Fujifilm said on April 9 that it will launch a PII clinical trial for its anti-flu drug Avigan (favipiravir) for the treatment of patients with the novel coronavirus disease COVID-19 in the US. It hopes to wrap up the program...read more